Spiriva 01
Spiriva Respimat Spray, Metered
Product Images NDC 0597-0100
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Spiriva Respimat (NDC 0597-0100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spiriva 02
This is a summary of clinical trial results comparing Spiriva Respimat to Placebo with 324 participants in the Spiriva group and 307 in the Placebo group. The graph appears to show the results of treatment for a certain condition over a period of weeks. The "means are adjusted for center, smoking status at entry and baseline value."*
Spiriva 03
This text appears to be a graph depicting the FEVI (forced expiratory volume in one second) response over time since drug administration for three different treatments - placebo, salmeterol and SPIRIVA RESPIMAT. The graph shows data points at the 0.4 hour, 3 hour and 1 hour mark, with lines connecting those points. The x-axis shows time since drug administration in hours, while the y-axis shows the FEVI response. The sample sizes for each treatment group are shown in parentheses.*
Spiriva 04
The text is describing the features of a mouthpiece device that has a dose-release button, safety catch, clear base, and a piercing element for two different cartridges called Aqua and Blue. These cartridges have different strengths, and the device is meant to be used by taking two puffs, once a day.*
Spiriva 05
This text is a product name or feature. It indicates a feature related to dosing, probably in medicine or chemical application, that is capable of measuring and indicating the amount or quantity.*
Spiriva 06
This text is a list of two different items and is not sufficient to provide a useful description.*
Spiriva 07
Spiriva 08
Spiriva 09
Spiriva 10
Spiriva 11
Spiriva 12
Spiriva 13
Spiriva 14
Spiriva 15
Spiriva 16
Spiriva 17
Spiriva Respimat is a tiotropium bromide inhalation spray. The package contents include each actuation delivers 25 meg and one Spiriva Respimat cartridge. The instructions state to insert the cartridge before use, and one dose is equal to two inhalations. The recommended dosage is 2.5 mcg/actuation, to be used once daily for oral inhalation only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
